title: [Image diagnosis: nuclear medicine].
abstract: Delineation of malignant tumor by scintigraphy is divided into two categories; visualizing tumor as positive foci or negative foci. Our clinical experiences with 67Ga, 201Tl, 131I-MIBG and 131Imonoclonal antibodies including 111In-ZMEO18 were described and literatures relevant to positive delineation of malignant tumor were reviewed.
authors.affiliation: Dept. of Nuclear Medicine, Kanazawa Univ.
authors.forename: K
authors.initials: K
authors.lastname: Hisada
authors.forename: N
authors.initials: N
authors.lastname: Tonami
authors.forename: T
authors.initials: T
authors.lastname: Michigishi
authors.forename: K
authors.initials: K
authors.lastname: Yokoyama
mesh_terms: D019797:3-Iodobenzylguanidine; D002951:Citrates; D019343:Citric Acid; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging; D009369:Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D012878:Skin Neoplasms / Q000000981:diagnostic imaging; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging
chemical_list: D002951:Citrates; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019343:Citric Acid; D019797:3-Iodobenzylguanidine